在讲法语的撒哈拉以南非洲地区使用酸
Jean-Benoît Arlet1, Françoise Bernaudin2, Indou Deme-Ly3,4
1Department of Internal Medicine, Georges Pompidou European Hospital, AP-HP, French National Reference Center for Sickle Cell Anemia, Thalassemia, Other Rare Red Blood Cell Disorders and Erythropoiesis, Paris, and Université Paris-Cité, Paris, France. jean-benoit.arlet@aphp.fr.
Annals of hematology
|February 5, 2025
概括
氧尿素是状细胞疾病 (SCD) 的重要药物,显著降低疼痛危机和死亡. 新的指导方针简化了撒哈拉以南非洲地区SCD患者的基尿素使用,解决了治疗优先事项,剂量和在低资源环境中的随访问题.
科学领域:
- 血液学 血液学 血液学
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 状细胞病 (SCD) 是撒哈拉以南非洲的主要健康负担.
- 基尿素是SCD管理中必不可少的,具有成本效益的药物,已被证明可以降低发病率和死亡率.
- 在该地区,有限的获取和不一致的基尿素处方阻碍了有效的SCD护理.
研究的目的:
- 制定在撒哈拉以南非洲国家使用氧尿素的实用治疗指南.
- 解决关键的临床问题,有关低资源环境中基尿素的启动,剂量和监测.
- 促进非洲SCD患者更广泛地采用和有效地实施基尿素.
主要方法:
- 科学咨询委员会制定基于证据的指导方针.
- 专注于对资源有限的环境的实际考虑.
- 为医疗保健从业者创建一个简洁的文件.
主要成果:
- 指导方针提供了明确的建议,以优先考虑患者的基尿素治疗.
- 具体的剂量建议概述了有效治疗的具体建议.
- 详细介绍了用于低资源环境的实际后续策略.
- 这些指导方针以英语和法语两种语言提供,以确保广泛的可访问性.
结论:
- 开发的指导方针为撒哈拉以南非洲的基尿素处方提供了一个简化,可操作的框架.
- 这些指导方针旨在通过优化基尿素利用来改善SCD患者的治疗结果.
- 该倡议支持Drep.Afrique的使命,即加强非洲各地的SCD护理.
相关概念视频
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Oral Hypoglycemic Agents: Sulfonylureas
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...


